Skip to content

Reducing Medication Errors and Time to Drugs Delivery During Pediatric Cardiopulmonary Resuscitation: a Multicenter RCT

Reducing Medication Errors and Time to Vasoactive Drugs Preparation and Delivery During Pediatric Cardiopulmonary Resuscitation: a Multicenter, Prospective, Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03021122
Enrollment
130
Registered
2017-01-13
Start date
2017-03-01
Completion date
2017-12-31
Last updated
2018-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatrics, Resuscitation

Keywords

Medication errors, Resuscitation, Drugs, Pediatrics, Biomedical technology

Brief summary

The investigators recruit nurses working in 5 swiss Pediatric Emergency Departments or divisions to prepare continuous infusions of vasoactive drugs during a simulation-based pediatric CPR cardiac arrest scenario. According to randomization, nurses will have to prepare and deliver vasoactive drugs following their current conventional methods or by the aim of a mobile tablet application called PedAMINES™. PedAMINES™ is designed to support them step-by-step from order to delivery of these drugs. 1. Primary outcome will be to measure in each allocation group the number of medication dosage errors committed during each drug preparation sequence until injection. 2. Secondary outcome will be to measure the time to drug preparation (TDP) and time to drug delivery (TDD).

Detailed description

During pediatric cardiopulmonary resuscitation (CPR), vasoactive drug preparation for continuous infusion is both complex and time-consuming, placing children at higher risk than adults for medication errors. It is well established that CPR duration is inversely correlated to survival, decreasing linearly by 2.1 % per minute, and to decreased risk of neurological sequelae \[1\]. In this study, the investigators recruit nurses working in 5 swiss Pediatric Emergency Departments or divisions to prepare continuous infusions of vasoactive drugs during a simulation-based pediatric CPR cardiac arrest scenario with a high-fidelity manikin (Laerdal SimJunior™). The scenario will take place in the shock room to increase realism. According to randomization with a 1:1 allocation ratio, nurses will have to prepare and deliver vasoactive drugs following their current conventional methods or by the aim of a mobile tablet application called PedAMINES™ (Pediatric Accurate Medication In Emergency Situations). PedAMINES™ is designed to support nurses step-by-step from order to delivery of a wide range of drugs, especially those requiring continuous infusion. PedAMINES™ has already been shown in a single-center simulation-based study to reduce time to vasoactive drug preparation, to delivery and the rate of medication errors \[2\]. On the day of participation, after obtaining nurse's written informed consent and randomization, nurses will receive a standardized 5-minute training session on how to use the app. Then, the nurses will be asked to perform a standardized 15-minute highly realistic CPR scenario, including post-return of spontaneous circulation (ROSC). After epinephrine-induced ROSC, nurses will be asked to first prepare a continuous infusion of dopamine, using either PedAMINES™ or a conventional method, and then a continuous infusion of norepinephrine by crossing the procedure. Moreover, 2 questionnaires will be given before and after the scenario to ask the nurses about their demographics data, perceived stress and degree of satisfaction. 1. Primary outcome will be to measure in each allocation group the number of medication dosage errors committed during each drug preparation sequence until injection. 2. Secondary outcome will be to measure the time to drug preparation (TDP) and time to drug delivery (TDD). All the actions (i.e. primary and secondary outcomes) performed by the nurses during the scenario will be automatically recorded and stored by the responsive simulator detectors, the application and by several video cameras. To avoid assessment bias, two evaluators will then independently review these video recordings. In case of disagreement, a third independent evaluator will help reach a consensus. We aim to determine whether the use of PedAMINES™ might improve the management of acute life-threatening conditions by quickly delivering expertise in vasoactive drugs administration in other hospitals in Switzerland, even in non-university hospitals where nurses (and physicians) are either little or not exposed to pediatric CPRs. We hypothesize that PedAMINES™ might primary reduce medication errors, and secondary reduce delays to drugs preparation and delivery independently of the existing conventional preparation methods or nurses' skills.

Interventions

DEVICEPedAMINES™ / Conventional Method

Each nurse will be asked to prepare a 5 μg/kg/min continuous infusion of dopamine (Period 1) and then to prepare a 0.1 μg/kg/min continuous infusion of norepinephrine (Period 2) for a 25kg boy using the studied delivery devices according to the sequence randomly assigned based on a cross-over design: • PedAMINES™ (Period 1) and then Conventional Method (Period 2)

DEVICEConventional Method / PedAMINES™

Each nurse will be asked to prepare a 5 μg/kg/min continuous infusion of dopamine (Period 1) and then to prepare a 0.1 μg/kg/min continuous infusion of norepinephrine (Period 2) for a 25kg boy using the studied delivery devices according to the sequence randomly assigned based on a cross-over design: • Conventional Method (Period 1) and then PedAMINES™ (Period 2)

Sponsors

University of Geneva, Switzerland
CollaboratorOTHER
University of Lausanne Hospitals
CollaboratorOTHER
Insel Gruppe AG, University Hospital Bern
CollaboratorOTHER
Neuchâtel Hospital, Neuchâtel, Switzerland
CollaboratorUNKNOWN
Fribourg Hospital, Fribourg, Switzerland
CollaboratorUNKNOWN
Sion Hospital, Sion, Switzerland
CollaboratorUNKNOWN
Pediatric Clinical Research Platform
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Blinding to the purpose of the study during recruitment will be maintained to minimize preparation bias. Nurses will be unblinded when the simulated scenario start.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* To be nurse certified * To know how to prepare intravenous drugs injection. * To have previously completed the 5-minute introductory course to the use of PedAMINES dispensed by the investigators of the study. * Participation agreement

Exclusion criteria

* To have at any time undergone a previous experiment with a cognitive numeric device aimed to help vasoactive drugs preparation. * To have not undergone the 5-minute introductory course to the use of PedAMINES.

Design outcomes

Primary

MeasureTime frameDescription
Medication dosage errorsOn the day of study participationTo measure in each allocation group the number of medication dosage errors committed during each drug preparation sequence until injection.

Secondary

MeasureTime frameDescription
Time to drug preparation (TDP) and time to drug delivery (TDD)On the day of study participationTo measure in each allocation group the elapsed time in seconds between the oral prescription by the physician to drug preparation completion by the nurse (TDP) and to drug delivery (TDD) by the nurse.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026